Categories: Latest

LANXESS extends collaboration with University of Massachusetts Amherst

New Delhi, November 09, 2018: Collaboration of Urethane Systems business unit with Polymer Science and Engineering department extended to CUMIRP Cluster M

Access to academic research on structure-property relationships, 3D printing and additive manufacturing

Next-generation materials for layer based manufacturing techniques

Cologne – LANXESS’ Urethane Systems business unit (URE) decided to prolong and extend its collaboration with the Center for UMass/Industry Research on Polymers (CUMIRP) at the University of Massachusetts Amherst, USA. From October 2018 onwards URE will additionally participate in Research Cluster M on Mechanics & Advanced Manufacturing of Polymers and Composites.

One of the cluster research areas is additive manufacturing technology innovation and next-generation 3D printing formulations. The focus in these efforts is to generate resins that have superior interfacial strength and enhanced sintering or reaction kinetics. Additive manufacturing is in the strategic focus of LANXESS Urethane Systems.

The CUMIRP Cluster M mainly works on understanding structure-process-property relationships of next-generation materials together with the development of new process methods or additives that simultaneously improve processability, and engineering properties. In the last few years the cluster has focused on applying this know-how to development of novel materials for additive manufacturing. “By joining this cluster, we will have access to the most recent technological developments in the field of 3D printing and additive manufacturing as well as to unique testing equipment targeted to screen materials for additive manufacturing and be part of a broader industrial community in this field,” says Dr. Polina Ware, head of Global Research and Development at URE. “Further, this collaboration will strengthen LANXESS’ relationship with UMass overall and help us in the long run to attract top talents.”

LANXESS expects cost savings from the collaboration through sophisticated, highly efficient solutions as well as benefits in business competition by using progressive technologies and the recruiting of qualified specialists. Furthermore, access to other companies who could be potential partners and/or customers will be provided.

Forward-Looking Statements:

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person’s officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Corporate Comm India(CCI NewsWire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

16 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

16 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

4 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

4 days ago